Physician profile
Georges Akl
NPI 1942597513
$1,771.90
in general payments reported to CMS, 2019-2025
11 companies · $829 in 2025
The $829 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $125 · 2021: $257 · 2022: $229 · 2023: $18.42 · 2024: $34.34 · 2025: $829.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $496 · Travel and Lodging: $386.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.65 |
| Travel and Lodging | $386.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $829.03 | 2025 | |
| Medtronic, INC. | $204.67 | 2022-2024 | Intellis Adaptivestim |
| Therapeuticsmd, INC. | $204.50 | 2019-2021 | |
| Myovant Sciences INC. | $152.27 | 2021 | |
| Pfizer INC. | $134.62 | 2019-2022 | |
| Lupin INC. | $107.38 | 2019 | |
| Abbvie INC. | $51.27 | 2019-2023 | Lo Loestrin Fe |
| Vertical Pharmaceuticals, LLC | $36.52 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.23 | 2019 | |
| Mayne Pharma Commercial LLC | $20.10 | 2022 | |
| Coopersurgical, INC. | $11.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Georges Akl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.